We observed that the combination of chemotherapeutic drugs with STING inhibitor further reduced tumor burden (Figure 6G) and SEI1 or PD‐L1 expression in myeloma cells (Figure 6H,I) compared with the use of chemotherapeutic drugs alone. This evidence concerns the gene SERTAD1 and plasma cell myeloma.